OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
226340$647.0056

Bonne Co Ltd

Personal ProductsVerified

Bonne Co Ltd has a market price of 647.0 KRW and a market cap of 27,143,189,860 KRW, with a price-to-book ratio of 0.78 and a price-to-tangible-book ratio of 0.78. The company's enterprise value to EBITDA is negative at -2.18, and its enterprise value to revenue is 0.77. The company's liquidity position is characterized by a current ratio of 1.46 and a debt-to-equity ratio of 0.46, indicating a moderate level of leverage. Profitability metrics show a return on equity of -42.72% and a return on assets of -26.32%, both significantly below the industry median for the Personal Products sector. The company reported a net loss of 14,826,147,730 KRW and an operating loss of 16,192,405,480 KRW, with a gross profit of 19,569,091,520 KRW. These figures indicate a challenging operating environment and a need for cost optimization or revenue growth. The company's revenue is concentrated in its core cosmetics business, with no disclosed geographic diversification. The lack of segment or geographic breakdown in the financial data suggests a high concentration risk, as the company's performance is tied to a single product line and likely a domestic market. Growth trajectory is uncertain, with the company reporting negative operating and free cash flows. The capital expenditure of -364,295,890 KRW indicates a reduction in investment, which may signal a defensive strategy or financial constraints. The outlook for the current fiscal year is not explicitly provided, but the negative cash flows and operating losses suggest a challenging period ahead. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. The company's financial structure and negative cash flows suggest a need for careful monitoring of liquidity and capital structure. Recent events include the company's transition from a special purpose acquisition company to a cosmetics manufacturer. No recent filings or transcripts are provided in the data, so the narrative is based on the latest available financial data and classification.

30-day price · 226340+12.00 (+1.9%)
Low$605.00High$870.00Close$647.00As of25 May, 00:00 UTC
Profile
CompanyBonne Co Ltd
Ticker226340.KQ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Bonne Co Ltd is a Korea-based company engaged in the manufacturing and distribution of cosmetics, including washable lotion, foundation, BB cream, CC cream, and other personal care products.

Classification. Bonne Co Ltd is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

Bonne Co Ltd has a market price of 647.0 KRW and a market cap of 27,143,189,860 KRW, with a price-to-book ratio of 0.78 and a price-to-tangible-book ratio of 0.78. The company's enterprise value to EBITDA is negative at -2.18, and its enterprise value to revenue is 0.77. The company's liquidity position is characterized by a current ratio of 1.46 and a debt-to-equity ratio of 0.46, indicating a moderate level of leverage. Profitability metrics show a return on equity of -42.72% and a return on assets of -26.32%, both significantly below the industry median for the Personal Products sector. The company reported a net loss of 14,826,147,730 KRW and an operating loss of 16,192,405,480 KRW, with a gross profit of 19,569,091,520 KRW. These figures indicate a challenging operating environment and a need for cost optimization or revenue growth. The company's revenue is concentrated in its core cosmetics business, with no disclosed geographic diversification. The lack of segment or geographic breakdown in the financial data suggests a high concentration risk, as the company's performance is tied to a single product line and likely a domestic market. Growth trajectory is uncertain, with the company reporting negative operating and free cash flows. The capital expenditure of -364,295,890 KRW indicates a reduction in investment, which may signal a defensive strategy or financial constraints. The outlook for the current fiscal year is not explicitly provided, but the negative cash flows and operating losses suggest a challenging period ahead. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. The company's financial structure and negative cash flows suggest a need for careful monitoring of liquidity and capital structure. Recent events include the company's transition from a special purpose acquisition company to a cosmetics manufacturer. No recent filings or transcripts are provided in the data, so the narrative is based on the latest available financial data and classification.
Key takeaways
  • Bonne Co Ltd operates in the Personal Products industry with a focus on cosmetics manufacturing and distribution.
  • The company is currently unprofitable, with a return on equity of -42.72% and a return on assets of -26.32%.
  • The company's liquidity position is moderate, with a current ratio of 1.46 and a debt-to-equity ratio of 0.46.
  • Revenue concentration in a single product line and domestic market increases business risk.
  • The company is experiencing negative cash flows and has reduced capital expenditures, indicating a defensive financial strategy.
  • The risk assessment highlights medium liquidity risk and low dilution risk.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$46.01B
Gross profit$19.57B
Operating income-$16.19B
Net income-$14.83B
R&D
SG&A
D&A
SBC
Operating cash flow-$6.08B
CapEx-$364.3M
Free cash flow-$14.98B
Total assets$56.34B
Total liabilities$21.63B
Total equity$34.71B
Cash & equivalents$7.85B
Long-term debt$15.97B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$647.00
Market cap$27.14B
Enterprise value$35.26B
P/E
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income
EV/OCF
P/B0.8
P/Tangible book0.8
Tangible book$34.71B
Net cash-$8.11B
Current ratio1.5
Debt/Equity0.5
ROA-26.3%
ROE-42.7%
Cash conversion41.0%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric226340Activity
Op margin-35.2%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin-32.2%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin42.5%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.8%-2.3% medp25 -4.4% · p75 -1.1%top quartile
Debt / equity46.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 08:03 UTC#f982e544
Market quoteclose KRW 647.00 · shares 0.04B diluted
no public URL
2026-05-04 08:03 UTC#0bee7636
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 08:04 UTCJob: ffefb913